Twister Biotech
Houston, US · Delaware corporation
Founders & leadership
CC
Christopher CokerNamed on SEC filing
MM
Mark MatovichNamed on SEC filing
LZ
Lynn ZechiedrichNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 2 rounds · 2020–2023
▶$500KraisedAug 2023 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Evan DaviesDirector
- Michael PaviaDirector
- Christopher CokerExecutive Officer, Director
- Alex StevenExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $500K
- Minimum investment
- $5K
- Proceeds to insiders
- $300K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedJan 2021 · 2 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJan 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher CokerExecutive Officer, Director
- Mark MatovichDirector
- Lynn ZechiedrichExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.1M
- Minimum investment
- $20K
- Proceeds to insiders
- $225K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Twister Biotech raised?
- Twister Biotech has disclosed $1.6M raised across 2 rounds.
- Where is Twister Biotech headquartered?
- Twister Biotech is headquartered in Houston, US.